Advertisement

The Use of Liposomes in Diagnostic Imaging

  • Vicente J. Caride

Abstract

The delivery of drugs to organs is determined by blood flow, lipid-water partition coefficient of the drug, ionization, drug stability and chemical structure. Using drug carriers the pharmacokinetics can be changed to make possible the selective drug delivery to normal and pathological tissues. Besides protecting the drug, the carrier facilitates the movement of the drug across anatomic and biochemical barriers to selected cells, tissues or organs (Gregoriadis, 1978). The three elements that influence drug distribution via carriers and are susceptible to manipulation are the drug carrier itself, the route (including the administration route and the path between the site of administration and the final destination) and the target tissue. Drug carriers, route and target have specific chemical, physical and anatomical features that deserve special consideration.

Keywords

Contrast Agent Drug Carrier Lipid Vesicle Administration Route Organ Distribution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abra, R.M. and Hunt, A., 1981, Liposome disposition in-vivo: III. Dose and vesicle size effects, Biochim. Biophys. Acta, 666: 493.PubMedCrossRefGoogle Scholar
  2. Alfidi, R.J. and Laval-Jeantet, M., 1976, A6 60:99: a promising contrast agent for computed tomography of the liver and spleen, Radiology, 121:491.PubMedGoogle Scholar
  3. Borowski, J., Roerdink, F. and Scherphof, G., 1977, Leakage of sucrose from phosphatidylcholine liposomes induced by interaction with serum albumin, Biochim. Biophys. Acta, 497:183.CrossRefGoogle Scholar
  4. Caride, V.J., 1981, Liposomes for diagnostic imaging, in: “Radiopharmaceuticals: structure activity relationships”, R.P. Spencer, ed., Grune & Stratton, New York.Google Scholar
  5. Caride, V.J., Taylor, W., Cramer, J.A. and Gottschalk, A., 1976, Evaluation of liposomes-entrapped radioactive tracers as scanning agents. Organ distribution of liposome (99m Tc DTPA) in mice, J. Nucl. Med., 17:1067.PubMedGoogle Scholar
  6. Caride, V.J, Sostman, H.D., Twickler, J., Zacharis, H., Orphanoudakis S.C. and Jaffe, C.C., 1982, Brominated radiopaque liposomes: contrast agents for computed tomography of liver and spleen. A preliminary report, Invest. Radiol., 17:381.PubMedCrossRefGoogle Scholar
  7. Dean, P.B., Violante, M.R. and Mohoney, J.A., 1980, Hepatic CT contrast enhancement: effect of dose, duration of infusion and time elapsed following infusion, Invest. Radiol., 15:158.PubMedCrossRefGoogle Scholar
  8. Espinola, L.G., Beaucaire, J., Gottschalk, A. and Caride, V.J., 1979. Radiolabeled liposomes as metabolic and scanning tracers in mice. (II) In III oxine compared with Tc 99m DTPA entrapped in multilamellar lipid vesicles, J. Nucl. Med., 20:434.PubMedGoogle Scholar
  9. Fischer, H.W., 1977. Improvement in radiographic contrast media through the development of colloidal or particulate media. An analysis, J. Theor. Biol., 67:653.PubMedCrossRefGoogle Scholar
  10. Gregoriadis, G., 1978, Liposomes in therapeutic and preventive medicine. The development of the drug carrier complex, An. N.Y. Acad. Sci., 308:343.CrossRefGoogle Scholar
  11. Havron, A., Seltzer, S.E., Davis, M.A. and Shulkin, P., 1981, Radiopaque liposomes: a promising new contrast material for computed tomography of the spleen, Radiology, 140:507.PubMedGoogle Scholar
  12. Juliano, R.L. and Stamp, D., 1975. The effect of particle size and charge on the clearance rates of liposomes and liposome-encapsulated drugs, Biochem. Biophys. Res. Comm., 63:651.PubMedCrossRefGoogle Scholar
  13. Lamarque, J.L., Bruel, J.M., Dondelinger, R., Vendrell, B., Pelissier, O., Rouanet, J.P., Michel, J.L. and Boulet, P., 1979, The use of iodolipids in hepatosplenic computed tomography, J. Comput. Assist. Tomogr., 3:21.PubMedCrossRefGoogle Scholar
  14. McDougall, I.R., Dunnick, J.K., Goris, M.L. and Kriss, J.P., 1975, In-vivo distribution of vesicles loaded with radiopharmaceutical: a study of different routes of administration, J. Nucl. Med., 16:488.PubMedGoogle Scholar
  15. Pagano, R.E. and Weinstein, J.N., 1978, Interactions of liposomes with mammalian cells, Ann. Rev. Biophys. Bioeng., 7:435.CrossRefGoogle Scholar
  16. Proffitt, R.J., Williams, L.E., Presant, C.A., Tin, G.W., Uliana, J.A., Gamble, R.C. and Baldeschwieler, J.D., 1983, Liposomal blockade of the reticuloendothelial system: Improved tumor imaging with small unilamellar vesicles, Science, 220:502.PubMedCrossRefGoogle Scholar
  17. Richardson, V.J., Jeyasingh, K., Jewkes, R.F., Ryman, B.E. and Tattersall, M.H., 1978, Possible tumor localization of Tc 99m labeled liposomes: effects of lipid composition, charge and liposome size, J. Nucl. Med., 19:1049.PubMedGoogle Scholar
  18. Seltzer, S.E., Adams, D.F., Davis, M.A., Hessel, S.J., Havron, A., Judy, P.F., Paskins-Hurlburt, A.J. and Hollenberg, N.K., 1981, Hepatic contrast agents for computed tomography: High atomic number particulate material, J. Comput. Assist. Tomogr., 5:370.PubMedCrossRefGoogle Scholar
  19. Senior, J. and Gregoriadis, G., 1982, Is half-life of circulating liposomes determined by changes in their permeability?, FEBS Lett., 145:109.PubMedCrossRefGoogle Scholar
  20. Vermess, M., Adamson, R.H., Doppman, J.L., Rabson, A.S. and Herdt, J.R., 1976, Intravenous hepatosplenography. Experimental evaluation of new contrast material, Radiology, 119:31.PubMedGoogle Scholar
  21. Strand, S.E. and Persson, B.R.R., 1979, Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits, J. Nucl. Med., 20:1038.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Vicente J. Caride
    • 1
    • 2
  1. 1.Nuclear Medicine DepartmentHospital of St. RaphaelNew HavenUSA
  2. 2.Department of Diagnostic ImagingYale University Medical SchoolNew HavenUSA

Personalised recommendations